Basilic vein transposition to enhance arteriovenous fistula venous outflow: a single-center technical note Authors: Xingjian Li, Dan Wu, Xiaowei Song, Bo Yang, Qiongli Liu, Chang You, Ying Shu, Lizhu Jin Published: 2026 ABSTRACT ObjectiveTo describe the technical feasibility and early clinical outcomes of basilic vein to fistula outflow vein transposition as an autogenous salvage option for malfunctioning forearm arteriovenous fistulas (AVFs) with venous outflow obstruction at the elbow level and a patent basilic vein.MethodsThis single-center retrospective technical note reviewed nine patients who underwent basilic vein to fistula outflow vein transposition between December 2023 and March 2026. Clinical indications, reasons for selecting surgical transposition over further endovascular treatment, operative details, time to postoperative dialysis use, complications, reinterventions, and individual access outcomes were summarized descriptively.ResultsThe mean age was 67.8 ± 7.2 years; seven patients were male. Hypertension was present in all patients and diabetes mellitus in two patients. The main clinical triggers for intervention were venous hypertension during hemodialysis, thrombotic occlusion of the cephalic outflow vein, and inadequate dialysis blood flow. The mean preoperative basilic vein diameter was 2.0 ± 0.28 mm. After reconstruction, all patients had restoration of a normal access thrill and resolution of abnormal fistula pulsatility, while intradialytic venous hypertension improved compared with the preoperative status. All AVFs were successfully used for hemodialysis within 48 h after surgery. Two patients had wound hemorrhage that resolved after bedside management. During follow-up, five patients required reintervention for restenosis, including PTA and open thrombectomy. No early thrombosis, hematoma, nerve injury, wound infection, clinically significant steal syndrome, or access abandonment occurred during the available follow-up.ConclusionIn patients with a functioning forearm AVF, preserved arterial inflow, elbow-level venous outflow obstruction, and a suitable basilic vein, basilic vein-to-fistula outflow vein transposition may represent a practical autogenous salvage option. These findings should be interpreted as preliminary technical experience. Introduction End-stage kidney disease (ESKD) represents a substantial global public health burden, and durable hemodialysis access remains central to the survival and quality of life of patients receiving maintenance dialysis [1]. Autologous arteriovenous fistula (AVF) is generally preferred when suitable vessels are available because it avoids prosthetic material and may offer favorable long-term access durability [2, 3]. AVF dysfunction caused by venous stenosis or occlusion remains common. Percutaneous transluminal angioplasty (PTA), with or without adjunctive stent placement, is frequently used for AVF stenosis because it is minimally invasive and repeatable [4–6]. However, repeated PTA may be ineffective in lesions with long-segment occlusion, severe elastic recoil, rapid recurrence, or unfavorable anatomy for safe stent placement. In a subset of forearm radiocephalic AVFs, venous outflow obstruction at the elbow level may coexist with a patent forearm basilic vein. When endovascular recanalization, repeat PTA, or stenting is unsuitable or has failed, transposition of the basilic vein to the fistula outflow vein can redirect venous drainage through an autogenous conduit while preserving the original arteriovenous anastomosis. In this technical note, we describe patient selection, operative technique, early usability for dialysis, complications, and individual follow-up outcomes of nine patients treated with this approach. Methods Patients and indications This was a single-center retrospective technical note based on electronic medical records supplemented by telephone follow-up. We identified nine patients who underwent basilic vein to fistula outflow vein transposition at our institution between December 2023 and March 2026. Demographic characteristics, clinical indications, operative findings, postoperative complications, reinterventions, and access status at the last available follow-up were abstracted. Patients were considered for transposition when they had a malfunctioning forearm AVF with venous outflow obstruction at the elbow level and a patent, mobilizable basilic vein. Clinical indicators prompting intervention included elevated venous pressure during hemodialysis, marked pulsatility of the fistula vein, Inadequate dialysis blood flow, recurrent stenosis after prior treatment, or thrombotic occlusion of the cephalic outflow vein. Further endovascular treatment was considered unsuitable or insufficient when one or more of the following features were present: long-segment occlusion or failed guidewire recanalization; high-grade elastic recoil or residual stenosis greater than 50% after angioplasty; restenosis requiring angioplasty at intervals shorter than 3 months; anatomic location across the elbow or cannulation segment with an inadequate landing zone for a covered stent; concern that stent placement would compromise future cannulation or surgical options; discontinuity of the native outflow vein after segmental resection; or clinical need for an autogenous reconstruction. During the study period, five nephrologists with dedicated vascular access training performed the procedures. Trained nephrologists routinely participate in ultrasound evaluation, endovascular treatment, and selected surgical reconstruction of hemodialysis access. Because the number of cases per operator was small, operator-level comparisons were not performed. Operative technique All patients underwent preoperative duplex ultrasonography to evaluate the inflow artery, original fistula vein, venous outflow anatomy, basilic vein diameter, wall quality, continuity, depth, and the feasibility of creating a tension-free subcutaneous tunnel. The basilic vein diameter was measured without the use of a proximal cuff or tourniquet. A basilic vein diameter of approximately 2.0 mm or greater, together with compressibility, continuity, and acceptable wall quality, was considered favorable for transposition [5]. The operation was performed under brachial plexus block combined with local infiltration anesthesia. After sterile preparation of the entire arm, a longitudinal incision was made over the preoperatively marked basilic vein. The basilic vein was carefully dissected, and its tributaries and communicating branches were ligated or divided. The distal end of the basilic vein was ligated with non-absorbable sutures, and the vein was gently dilated with normal saline to confirm continuity and caliber. A second incision was made over the fistula outflow vein near the obstructed segment at a site suitable for anastomosis. A subcutaneous tunnel was created without tension or twisting, and the mobilized basilic vein was brought through the tunnel. An end-to-side anastomosis was then created between the basilic vein and the fistula outflow vein using non-absorbable sutures (Fig. 1). After clamp release, intraoperative patency was assessed by visible filling of the transposed basilic vein, palpation for a continuous thrill, and intraoperative Doppler ultrasonography. After wound closure, auscultation was also performed to confirm the presence of a vascular bruit. Completion angiography was not routinely performed.Fig. 1Schematic drawing of the surgery. a The lesion segments of AVF. b The basilic vein transposition to the fistula outflow vein Schematic drawing of the surgery. a The lesion segments of AVF. b The basilic vein transposition to the fistula outflow vein Follow-up and outcome assessment All patients were admitted for perioperative management and coordination of inpatient hemodialysis. During hospitalization, patients underwent preoperative laboratory testing and duplex ultrasonography, surgical reconstruction, scheduled hemodialysis after the procedure, and management of relevant comorbidities. Most patients were discharged after successful hemodialysis through the reconstructed fistula. The reconstructed access was examined on postoperative day 1 for a continuous thrill and audible bruit. The fistula was used for hemodialysis when the treating team judged the access clinically usable; in this series, all AVFs were cannulated and used within 48 h postoperatively. Early complications, including bleeding, hematoma, infection, thrombosis, nerve injury, and steal symptoms, were assessed before discharge and during early follow-up. Doppler ultrasonography was performed 30–45 days after reconstruction to assess venous diameter, depth, flow, and focal stenosis or aneurysmal change. Subsequent follow-up was scheduled every 3–6 months and included history-taking, physical examination, dialysis venous pressure review, and ultrasound assessment when clinically indicated. If access dysfunction was suspected, biplane Doppler ultrasonography was performed to evaluate inflow, outflow, and hemodynamics. Clinical outcomes included technical success, time to first postoperative cannulation, primary failure, access abandonment, access-related complications, and reinterventions during follow-up. Primary failure was defined as inability to use the AVF or the need for a new AVF or intervention within 30 days. Access abandonment was defined as permanent discontinuation of the access for dialysis [3]. Postoperative complications included bleeding, hematoma, infection, thrombosis, nerve injury, steal symptoms, restenosis, and other access-related adverse events. Statistical analysis Continuous variables are reported as mean ± standard deviation, and categorical variables are reported as number and percentage. No comparative analysis or survival modeling was performed because of the small sample size and variable follow-up duration. Results The baseline characteristics of the nine patients are summarized in Table 1. Seven patients were male and two were female. The mean age was 67.78 ± 7.17 years. All patients had hypertension, and two patients (22.2%) had diabetes mellitus. Six patients presented with venous hypertension during hemodialysis, one patient presented with thrombotic occlusion of the cephalic outflow vein, and two patients presented with inadequate dialysis blood flow during hemodialysis.Table 1Patient demographics and baseline characteristicsBaselineValue (n = 9)Age at access placement, years67.78 ± 7.17Men7 (77.8)Body mass index, kg/m221.8 ± 3.8Comorbidities Diabetes mellitus2 (22.2) Hypertension9 (100) Cardiovascular diseases1 (11.1) Congestive heart failure2 (22.2) Hyperlipidemia2 (22.2) Hypercoagulability0 (0)Smoking history4 (44.4)Preoperative VP HD*, mmHg166.78 ± 48.22Non-tunneled central venous catheter1 (11.1)Statin1 (11.1)Aspirin0 (0)Warfarin0 (0)Preoperative basilic vein diameter, mm2.0 ± 0.28VP HD Venous pressure during hemodialysis Table 1Patient demographics and baseline characteristicsBaselineValue (n = 9)Age at access placement, years67.78 ± 7.17Men7 (77.8)Body mass index, kg/m221.8 ± 3.8Comorbidities Diabetes mellitus2 (22.2) Hypertension9 (100) Cardiovascular diseases1 (11.1) Congestive heart failure2 (22.2) Hyperlipidemia2 (22.2) Hypercoagulability0 (0)Smoking history4 (44.4)Preoperative VP HD*, mmHg166.78 ± 48.22Non-tunneled central venous catheter1 (11.1)Statin1 (11.1)Aspirin0 (0)Warfarin0 (0)Preoperative basilic vein diameter, mm2.0 ± 0.28VP HD Venous pressure during hemodialysis Patient demographics and baseline characteristics VP HD Venous pressure during hemodialysis Preoperative duplex ultrasonography showed a mean basilic vein diameter of 2.0 ± 0.28 mm. The mean operative time was 129.67 ± 37.55 min, and the mean hospital stay was 5.0 ± 1.94 days. All patients underwent end-to-side anastomosis of the transposed basilic vein to the fistula outflow vein. Four patients also underwent adjunctive angioplasty of the fistula outflow vein, two patients underwent open thrombectomy, and one patient underwent resection of an infected fistula segment. After reconstruction, a palpable thrill returned in all accesses, venous pulsatility was attenuated, and intradialytic venous hypertension improved compared with the preoperative status. All AVFs were successfully used for hemodialysis within 48 h postoperatively. Mean intrafistular venous pressure during dialysis decreased significantly relative to preoperative values (166.78 ± 48.22 vs 90.00 ± 35.21). One patient’s central venous catheter was removed on postoperative day 2. Two patients developed wound hemorrhage that resolved after bedside management. No hematoma, early access thrombosis, nerve injury, wound infection, or clinically significant access-related steal syndrome was observed. The mean follow-up duration was 16.20 ± 7.34 months. One patient died 3 months after surgery from a cause unrelated to the procedure or access complications. Five patients developed restenosis requiring reintervention during follow-up, including 11 PTA procedures and two open thrombectomy procedures. No stent placement or access abandonment occurred during the available follow-up. Outcomes are reported descriptively, and individual patient data are presented in Table 2.Table 2Individual patient characteristics, indications, and outcomes after transpositionPatientClinical trigger for interventionReason for transpositionTime to first postoperative HD useFollow-up, monthsReinterventions after transpositionAccess status at last follow-up1Venous hypertensionUpper-arm cephalic vein occlusion; no communicating branch; failed guidewire crossingSame day27.2PTA × 2; open thrombectomy × 1Functional2Venous hypertensionUpper-arm cephalic vein occlusion; occluded communicating branch; failed guidewire crossingSame day14.7PTA × 2Functional3Venous hypertensionElbow-level cephalic vein occlusion; occluded communicating branch; failed guidewire crossingPOD* 115.0PTA × 2; open thrombectomy × 1Functional4Thrombotic occlusionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 113.9NoneFunctional5Inadequate dialysis blood flowElbow-level cephalic vein stenosis with severe elastic recoil after PTA*; stent avoidedPOD* 112.2NoneFunctional6Venous hypertension with infection of the cannulation segmentInfected fistula segment requiring resectionSame day16.7NoneFunctional7Venous hypertensionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 12.1None before deathDied unrelated to access8Venous hypertensionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 125.2PTA × 4Functional9Inadequate dialysis blood flowRecurrent elbow-level cephalic vein stenosis; stent avoidedSame day18.7PTA × 1FunctionalPTA Percutaneous transluminal angioplasty, POD Postoperative day Table 2Individual patient characteristics, indications, and outcomes after transpositionPatientClinical trigger for interventionReason for transpositionTime to first postoperative HD useFollow-up, monthsReinterventions after transpositionAccess status at last follow-up1Venous hypertensionUpper-arm cephalic vein occlusion; no communicating branch; failed guidewire crossingSame day27.2PTA × 2; open thrombectomy × 1Functional2Venous hypertensionUpper-arm cephalic vein occlusion; occluded communicating branch; failed guidewire crossingSame day14.7PTA × 2Functional3Venous hypertensionElbow-level cephalic vein occlusion; occluded communicating branch; failed guidewire crossingPOD* 115.0PTA × 2; open thrombectomy × 1Functional4Thrombotic occlusionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 113.9NoneFunctional5Inadequate dialysis blood flowElbow-level cephalic vein stenosis with severe elastic recoil after PTA*; stent avoidedPOD* 112.2NoneFunctional6Venous hypertension with infection of the cannulation segmentInfected fistula segment requiring resectionSame day16.7NoneFunctional7Venous hypertensionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 12.1None before deathDied unrelated to access8Venous hypertensionRecurrent elbow-level cephalic vein stenosis; stent avoidedPOD* 125.2PTA × 4Functional9Inadequate dialysis blood flowRecurrent elbow-level cephalic vein stenosis; stent avoidedSame day18.7PTA × 1FunctionalPTA Percutaneous transluminal angioplasty, POD Postoperative day Individual patient characteristics, indications, and outcomes after transposition PTA Percutaneous transluminal angioplasty, POD Postoperative day Discussion Current international consensus emphasizes that vascular access salvage should be prioritized whenever feasible before abandonment, particularly in patients with limited remaining venous options [5]. Basilic vein-to-fistula outflow vein transposition provides an autogenous salvage option for selected patients with malfunctioning forearm AVFs and limited superficial venous outflow. The technique preserves the original arterial inflow of the existing AVF and redirects venous drainage through a mobilized basilic vein. In the present series, immediate technical success was achieved in all patients, all accesses were used for hemodialysis within 48 h after surgery, and no early access loss occurred. The potential value of this approach lies in patients whose original AVF retains adequate arterial inflow but has elbow-level venous outflow obstruction that is difficult to manage durably with endovascular treatment alone. In such cases, conventional endovascular strategies may be limited by rapid recurrent restenosis, severe elastic recoil after PTA, failed guidewire recanalization, long-segment occlusion, or interruption of the outflow vein after segmental resection [6]. Stent placement may also be less suitable when lesions are close to the elbow flexion zone or cannulation segment, when an adequate landing zone is lacking, or when future access options may be compromised [3, 7]. Under these circumstances, rerouting venous drainage through an available basilic vein may represent a rational salvage strategy. Several surgical alternatives have been used for complex failing AVFs, including creation of a new brachiobasilic fistula, prosthetic graft revision, short-segment interposition grafting, and bypass procedures [8, 9]. Brachiobasilic fistula creation can provide durable autogenous access, but it usually represents construction of a new access circuit and may require additional maturation time [10, 11]. Prosthetic graft-based strategies can be useful when autogenous venous options are limited, but they introduce foreign material and are associated with risks of infection, thrombosis, and recurrent anastomotic stenosis [12]. The present technique differs from these approaches in that it adds an autogenous outflow pathway while preserving the existing access and avoiding prosthetic material. The early safety profile in this series was acceptable. Wound hemorrhage occurred in two patients and was managed successfully with bedside treatment. No early access thrombosis, wound infection, nerve injury, or clinically significant access-related steal syndrome was observed. The absence of clinically significant steal may be related to preservation of the original inflow rather than creation of a new high-flow arterial anastomosis, although this observation requires confirmation in larger cohorts. During follow-up, restenosis requiring reintervention remained the main access-related event, highlighting the need for continued clinical surveillance and timely ultrasound evaluation when venous pressure elevation, recurrent pulsatility, difficult cannulation, or reduced dialysis blood flow occurs. This study has several limitations. It was a retrospective, single-center case series involving only nine highly selected patients with preserved arterial inflow and suitable basilic vein anatomy. The absence of a control group precludes direct comparison with repeat PTA, stent placement, prosthetic graft revision, or new access creation. In addition, follow-up duration was variable, and the sample size was insufficient to provide robust estimates of long-term patency. Therefore, the findings should be interpreted as preliminary technical experience supporting feasibility rather than definitive evidence of long-term efficacy. Larger multicenter studies with standardized ultrasound surveillance, longer follow-up, and comparative treatment groups are needed to better define patient selection, durability, reintervention burden, and cost-effectiveness. Conclusion Basilic vein to fistula outflow vein transposition may be a useful autogenous salvage option for carefully selected patients with forearm AVF venous outflow obstruction at the elbow level and a patent basilic vein when further endovascular treatment is unsuitable or has failed. The technique preserves the original arteriovenous anastomosis, can permit early postoperative dialysis use, and avoids prosthetic material. Given the small sample size and variable follow-up, its long-term durability should be confirmed in larger comparative studies.